Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Blood Testing Startup Sight Diagnostics Reveals Investors in $28 Million Round

The company announced the private issuance in December via shareholder Clal Biotechnology Industries

CTech 14:1818.02.19
TAGS:
Blood testing startup S.D. Sight Diagnostics Ltd. has announced additional details regarding its $27.8 series C round, first announced in December via its shareholder Clal Biotechnology Industries Ltd. On Thursday, the company revealed the round was led by Longliv Ventures, a member of multinational health and beauty conglomerate the CK Hutchison Group. Existing investors OurCrowd, Go Capital, and New Alliance Capital also participated.

 

Sight stated it will use the funding for research and development.

 

Blood test (illustration). Photo: Shutterstock Blood test (illustration). Photo: Shutterstock

 

Zero Comments
Cancel Send
    To all comments